Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis

Annals of the Rheumatic Diseases

Volumn 75, Issue 7, 2016, Pages 1372-1379

  Nasi, Sonia ^a   So, Alexander ^a   Combes, Christèle ^b   Daudon, Michel ^c   Busso, Nathalie ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CYTOKINE; HYDROXYAPATITE; INTERLEUKIN 6; JANUS KINASE 2; LIPOCORTIN 5; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN ANK; PROTEIN KINASE SYK; PROTEOGLYCAN; SODIUM PHOSPHATE COTRANSPORTER; STAT3 PROTEIN; TRANSCRIPTION FACTOR PIT 1; UNCLASSIFIED DRUG; CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BONE MINERALIZATION; CALCIFICATION; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE EXPLANT; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL OSTEOARTHRITIS; FEEDBACK SYSTEM; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; MENISCECTOMY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CHONDROCYTE; DISEASE MODEL; EXPERIMENTAL ARTHRITIS; METABOLISM; OSTEOARTHRITIS; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CALCIFICATION, PHYSIOLOGIC; CALCIUM CHANNELS; CALCIUM PHOSPHATES; CHONDROCYTES; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-6; MICE; OSTEOARTHRITIS;

EID: 84940204028     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207487     Document Type: Article

References (51)

1. Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum 2012;64:1697-707.
2. Nalbant S, Martinez JA, Kitumnuaypong T, et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 2003;11:50-4.
3. Fuerst M, Bertrand J, Lammers L, et al. Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 2009;60:2694-703.
4. Fuerst M, Niggemeyer O, Lammers L, et al. Articular cartilage mineralization in osteoarthritis of the hip. BMC Musculoskelet Disord 2009;10:166.
5. Scotchford CA, Greenwald S, Ali SY. Calcium phosphate crystal distribution in the superficial zone of human femoral head articular cartilage. J Anat 1992;181(Pt 2):293-300.
6. Mitsuyama H, Healey RM, Terkeltaub RA, et al. Calcification of human articular knee cartilage is primarily an effect of aging rather than osteoarthritis. Osteoarthritis Cartilage 2007;15:559-65.
7. Ea HK, Liote F. Advances in understanding calcium-containing crystal disease. Curr Opin Rheumatol 2009;21:150-7.
8. Liote F, Ea HK. Clinical implications of pathogenic calcium crystals. Curr Opin Rheumatol 2014;26:192-6.
9. Ea HK, Nguyen C, Bazin D, et al. Articular cartilage calcification in osteoarthritis: Insights into crystal-induced stress. Arthritis Rheum 2011;63:10-18.
10. Gurley KA, Reimer RJ, Kingsley DM. Biochemical and genetic analysis of ANK in arthritis and bone disease. Am J Hum Genet 2006;79:1017-29.
11. Gurley KA, Chen H, Guenther C, et al. Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res 2006;21:1238-47.
12. Bertrand J, Nitschke Y, Fuerst M, et al. Decreased levels of nucleotide pyrophosphatase phosphodiesterase 1 are associated with cartilage calcification in osteoarthritis and trigger osteoarthritic changes in mice. Ann Rheum Dis 2012;71:1249-53.
13. Sun Y, Mauerhan DR, Honeycutt PR, et al. Calcium deposition in osteoarthritic meniscus and meniscal cell culture. Arthritis Res Ther 2010;12:R56.
14. Ea HK, Chobaz V, Nguyen C, et al. Pathogenic role of basic calcium phosphate crystals in destructive arthropathies. PLoS ONE 2013;8:e57352.
15. McCarthy GM, Augustine JA, Baldwin AS, et al. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein 1, and protein kinase c. J Biol Chem 1998;273:35161-9.
16. Nair D, Misra RP, Sallis JD, et al. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 1997;272:18920-5.
17. Brogley MA, Cruz M, Cheung HS. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway. J Cell Physiol 1999;180:215-24.
18. Sun Y, Wenger L, Brinckerhoff CE, et al. Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. J Biol Chem 2002;277:1544-52.
19. Reuben PM, Sun Y, Cheung HS. Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts. J Biol Chem 2004;279:35719-25.
20. Ea HK, Uzan B, Rey C, et al. Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes. Arthritis Res Ther 2005;7:915-926.
21. Cunningham CC, Mills E, Mielke LA, et al. Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase. Clin Immunol 2012;144:228-36.
22. McCarthy GM, Westfall PR, Masuda I, et al. Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes. Ann Rheum Dis 2001;60:399-406.
23. Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum 2009;60:2037-45.
24. Hashizume M, Mihara M. Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production. Osteoarthritis Cartilage 2009;17:1513-18.
25. Suzuki M, Hashizume M, Yoshida H, et al. IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression. Cytokine 2010;51:178-83.
26. Sui Y, Lee JH, DiMicco MA, et al. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Arthritis Rheum 2009;60:2985-96.
27. Ryu JH, Yang S, Shin Y, et al. Interleukin-6 plays an essential role in hypoxia-inducible factor 2alpha-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum 2011;63:2732-43.
28. Kamekura S, Hoshi K, Shimoaka T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005;13:632-41.
29. Nasi S, Ea HK, Chobaz V, et al. Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine 2014;81:320-4.
30. van Lent, PL, Grevers LC, Blom AB, et al. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 2008;58:3776-87.
31. Prudhommeaux F, Schiltz C, Liote F, et al. Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum 1996;39:1319-26.
32. Gosset M, Berenbaum F, Thirion S, et al. Primary culture and phenotyping of murine chondrocytes. Nat Protoc 2008;3:1253-60.
33. Estepa-Maurice L, Hennequin C, Marfisi C, et al. Fourier transform infrared microscopy identification of crystal deposits in tissues: clinical importance in various pathologies. Am J Clin Pathol 1996;105:576-82.
34. Nguyen C, Ea HK, Thiaudiere D, et al. Calcifications in human osteoarthritic articular cartilage: Ex vivo assessment of calcium compounds using XANES spectroscopy. J Synchrotron Radiat 2011;18:475-80.
35. Gregory CA, Gunn WG, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329:77-84.
36. Tremoleda JL, Khalil M, Gompels LL, et al. Imaging technologies for preclinical models of bone and joint disorders. EJNMMI Res 2011;1:11.
37. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007;15:1061-9.
38. Sampson ER, Beck CA, Ketz J, et al. Establishment of an index with increased sensitivity for assessing murine arthritis. J Orthop Res 2011;29:1145-51.
39. Aini H, Ochi H, Iwata M, et al. Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model. PLoS ONE 2012;7:e37728.
40. Mueller MB, Tuan RS. Anabolic/Catabolic balance in pathogenesis of osteoarthritis: Identifying molecular targets. PM R 2011;3:3-11.
41. Fuerst M, Zustin J, Lohmann C, et al. [Synovial chondromatosis]. Orthopade 2009;38:511-19.
42. Fukui K, Kaneuji A, Amaya S, et al. Synovial osteochondromatosis of the hip with femoroacetabular impingement and osteoarthritis: A case report. J Orthop Surg (Hong Kong) 2013;21:117-21.
43. Ladefoged C. Amyloid in osteoarthritic hip joints: deposits in relation to chondromatosis, pyrophosphate, and inflammatory cell infiltrate in the synovial membrane and fibrous capsule. Ann Rheum Dis 1983;42:659-64.
44. Nguyen C, Lieberherr M, Bordat C, et al. Intracellular calcium oscillations in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation. Osteoarthritis Cartilage 2012;20:1399-408.
45. Ea HK, Monceau V, Camors E, et al. Annexin 5 overexpression increased articular chondrocyte apoptosis induced by basic calcium phosphate crystals. Ann Rheum Dis 2008;67:1617-25.
46. Poree B, Kypriotou M, Chadjichristos C, et al. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J Biol Chem 2008;283:4850-65.
47. Van Wagoner, NJ, Choi C, Repovic P, et al. Oncostatin M regulation of interleukin-6 expression in astrocytes: Biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38. J Neurochem 2000;75:563-75.
48. Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012-19.
49. Zaka R, Stokes D, Dion AS, et al. P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells. Arthritis Res Ther 2006;8:R164.
50. Kirsch T, Swoboda B, Nah H. Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Osteoarthritis Cartilage 2000;8:294-302.
51. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 2006;98:905-12.